E
INSP icon

Ergoteles’s Inspire Medical Systems INSP Stock Holding History

Ergoteles’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-43,753
Closed -$14.2M – 436
2023
Q2 		$14.2M Buy
43,753
+42,438
+3,227% +$12.1M 0.68% 15
2023
Q1 		$308K Buy
+1,315
New +$332K 0.01% 886
2022
Q4 		– Sell
-2,869
Closed -$509K – 1660
2022
Q3 		$509K Sell
2,869
-2,788
-49% -$560K 0.02% 753
2022
Q2 		$1.03M Buy
+5,657
New +$1.13M 0.03% 530
2022
Q1 		– Sell
-3,288
Closed -$756K – 1417
2021
Q4 		$756K Buy
+3,288
New +$803K 0.03% 497
2021
Q3 		– Sell
-11,307
Closed -$2.19M – 1431
2021
Q2 		$2.19M Buy
11,307
+8,307
+277% +$1.65M 0.05% 351
2021
Q1 		$621K Buy
+3,000
New +$638K 0.02% 442

Other funds holding INSP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Ergoteles's INSP Position: Q3 2023 in Review

Ergoteles sold out of Inspire Medical Systems (INSP) in Q3 2023, closing a stake of 43,753 shares — an estimated $14.2M sold.

Ergoteles first reported a position in INSP in Q1 2021 and held it in 7 quarters. The position peaked at $14.2M in Q2 2023. 364 funds tracked by Wall St. Rank hold INSP as of Q3 2023.

  • Ergoteles reported no remaining Inspire Medical Systems position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 43,753 Inspire Medical Systems shares in Q3 2023, an estimated $14.2M.
  • Ergoteles first reported a position in Inspire Medical Systems in Q1 2021 and held it in 7 quarters.
  • Ergoteles's Inspire Medical Systems position peaked at $14.2M in Q2 2023.
  • 364 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.